Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice

Topic: Disease mechanisms in lab and animal studies

beta amyloid protein (Abeta) is a 40-43 amino acid peptide derived from amyloid precursor protein (APP). Abeta has been implicated as a cause of Alzheimer's disease (AD). Mice with spontaneous or transgenic overexpression of APP show the histologic hallmarks of AD and have impairments in learning and memory. We tested whether antisense phosphorothiolated oligonucleotides (AO) directed at the Abeta region of the APP gene given with or without antibody directed at Abeta could reverse the elevated protein levels of APP and the behavioral impairments seen in SAMP8 mice, a strain which spontaneously overexpresses APP. We found that intracerebroventricular (ICV) administration of antibody with either of two AOs directed at the midregion of Abeta improved acquisition and retention in a footshock avoidance paradigm, whereas two AOs directed more toward the C-terminal, a random AO, and vehicle were without effect. Three injections of the more potent AO given without antibody reduced APP protein levels by 43-68% in the amygdala, septum, and hippocampus. These results show that AO directed at the Abeta region of APP can reduce APP levels in the brain and reverse deficits in learning and memory.

Key findings

• We found that intracerebroventricular (ICV) administration of antibody with either of two AOs directed at the midregion of Abeta improved acquisition and retention in a footshock avoidance paradigm, whereas two AOs directed more toward the C-terminal, a random AO, and vehicle were without effect.
• These results show that AO directed at the Abeta region of APP can reduce APP levels in the brain and reverse deficits in learning and memory.

New to this subject? Start with our plain-English guide: Treatments →

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1016/s0196-9781(00)00339-9
• PubMed: 11150636
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{kumar2000-11150636,
  author  = {Kumar, V. B. and Farr, S. A. and Flood, J. F. and Kamlesh, V. and Franko, M. and Banks, W. A. and Morley, J. E.},
  title   = {{Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice}},
  journal = {Peptides},
  year    = {2000},
  doi     = {10.1016/s0196-9781(00)00339-9},
  pmid    = {11150636},
  url     = {https://doi.org/10.1016/s0196-9781(00)00339-9}
}

Related studies in Drug development

• Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease Free radical biology & medicine · 2013-12-16 · usefulness score 36/100
• Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice Brain research · 2004-08-01 · usefulness score 36/100
• Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model Brain pathology (Zurich, Switzerland) · 2014-02-12 · usefulness score 40/100
• Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice Experimental neurology · 2012-10-08 · usefulness score 36/100
• Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits Aging cell · 2018-05-10 · usefulness score 41/100
• Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide Nature medicine · 2021-12-23 · usefulness score 45/100

Also tagged “presenilin”

343 studies in the library carry the topic tag “presenilin”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 343 tagged studies.

• Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers Molecular neurodegeneration · 2007-09-26 · usefulness score 40/100 · Risk factors
• Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch) Science (New York, N.Y.) · 1990-06-01 · usefulness score 41/100 · Down syndrome and Alzheimer's
• Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model Neurobiology of disease · 2000-08-01 · usefulness score 36/100 · Risk genes beyond APOE

Similar studies

• Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model 2002 · Tau biomarkers
• Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 2001 · Risk genes beyond APOE
• Deciphering the molecular basis of memory failure in Alzheimer's disease 2004 · Disease mechanisms
• A specific amyloid-beta protein assembly in the brain impairs memory 2006 · Brain tissue and pathology
• Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss 2003 · Disease mechanisms
• A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease 2000 · Risk genes beyond APOE

More on Drug development

• A review that covers this ground Antisense Oligonucleotide Therapies for Neurodegenerative Diseases Annual review of neuroscience · 2019-07-01 · usefulness score 38/100
• Newest in this subject The metabolic-brain axis: GLP-1 signaling, insulin resistance, and obesity pharmacotherapy in neurodegeneration Metabolism: clinical and experimental · 2026-10-30 · Peer-reviewed · usefulness score 45/100
• Newest in this subject Effect of Metformin on tau pathology and proteostasis in cellular and a Drosophila model of Tauopathy Research Square · 2026-10-29 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Drug development →